2 years ago

Lindus Health Raises $6 Million Led by Peter Thiel to Accelerate Clinical Trials

  • Lindus Health, a UK-based clinical trial software developer, has secured $6 million in funding from investors including Peter Thiel, Firstminute Capital, Seedcamp, Hambro Perks, and Calm/Storm

  • The company's software has been used in over 80 trials in the UK, US, and Europe since its launch in 2021

  • Lindus Health aims to accelerate the clinical trials process by simplifying and streamlining the process, putting patients first

  • The company is currently working with Pharmanovia on trials for insomnia and with Oto on a digital tinnitus trial.

      • ProblemHealthcare

      "Clinical trials are the biggest bottleneck to improving human health. They are slow, expensive, and difficult to manage."

      Solution

      "Lindus Health is building a software platform that simplifies and accelerates the clinical trials process. The platform helps organizers conduct study design, recruitment, and delivery, and uses machine learning to predict trial outcomes and make improvements to trial designs in advance."

      Covered on